Cognitive Effects of Treatment of Interictal Discharges

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Epilepsy
Interventions
DRUG

levetiracetam

The dosage of levetiracetam will begin at 500mg twice per day (bid) for the first 4 days, and increase by 500mg every 5 days thereafter until a goal of 1500mg bid is reached. The subject will then remain on levetiracetam at 1500mg bid for 8 weeks, until the conclusion of the study. Medication will be supplied in 500mg tablets, to be taken orally.

DRUG

Lamotrigine

"The drug will be supplied in 25, 100 and 150mg tablets, to be taken orally per the titration schedule below:~The regimen will begin at 25mg once per day for the first two weeks, and increase to 50mg once per day during weeks 3 and 4. In week 5, the subject will take 50mg twice per day (bid). The dosage will increase to 50mg in the morning and 100mg at night during week 6. During week 7 the subject will take 100mg bid. During week 8, the subject will take 100mg in the morning and 150mg at night. At week 9, the subject will reach the target dose of 150mg bid. The subject will then remain on lamotrigine at 150mg bid for 7 weeks, until the conclusion of the study."

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

UCB Young Investigator Research Program

UNKNOWN

collaborator

National EpiFellows Foundation

UNKNOWN

collaborator

UCB Pharma

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00916149 - Cognitive Effects of Treatment of Interictal Discharges | Biotech Hunter | Biotech Hunter